Health Optimization Index
NAD+
- Nick’s assessment
- Experimental
- Research evidence
- D, early evidence
- Attention
- 10.3 / 100▲ Rising this week
BioHarmony score
NAD+ is a coenzyme central to energy metabolism and DNA repair, now marketed as intravenous, injectable and intranasal therapy for aging, energy and focus. The strongest human study is a six-person pilot showing an IV infusion changes the plasma NAD+ metabolome, not a controlled outcome trial. Independent reviews find no completed randomized trial proving that infused NAD+ reaches tissues intact or produces the advertised benefits, while oral precursors NMN and NR have better safety data.
Surfaced from industry newsletters. It enters at Experimental until the evidence is graded.
Read Nick’s assessment Why it earned this rating
Direct NAD+ administration sits in an honest tension: the underlying biology is excellent, and the human evidence for the drips, injections and sprays being sold is not. NAD+ is essential, declines with age, and restores healthspan markers in animals, but the leap to infusing it into people has been tested mainly in a six-person metabolite pilot rather than in controlled outcome trials (Grant 2019). Independent reviewers reach the same verdict and point to precursors as the better-supported route (Rajman 2018). That is why the score of lands in the middle: real mechanism, high reversibility and tolerable short infusions, set against a steep price, uncharacterized long-term safety and a cheaper oral alternative with actual trial data. Nothing here supports NAD+ as a proven cure for addiction, dementia or aging, and nothing supports buying it from unregulated supply.
✅ Best for: Adults who understand they are paying for a mechanistic bet rather than proven therapy and want it supervised in a clinic; people drawn to the NAD+ story who would be equally served, at far lower cost and with better evidence, by discussing oral precursors with a clinician; and anyone who will track their own energy and clarity honestly against the possibility of a placebo effect.
❌ Avoid if: You are being sold NAD+ as a proven treatment for addiction, neurodegeneration or aging; you would be substituting it for evidence-based medical care; you are considering compounded product from an unlicensed or unverified source; you are sensitive to infusion-reaction symptoms and cannot tolerate a slow drip; or the cost would displace spending on interventions with real human outcome data.
Share your experience
Your answers are optional and help other readers — they never change my score. How community input works.
One step left: confirm it’s you
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.
Make a 12-month prediction Will it rise or fall in the Index?
Choose a direction and your confidence. Correct predictions earn leaderboard points.
Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →